Phishing attacks are predicted to increase by over 100% during Thanksgiving week as employees spend more time online, according to a Lookout report.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
